Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
albumin human 2 g/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cisatracurium 150 mg/30 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
albumin human 20 g/500 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
albumin human 20 g/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cisatracurium 10 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
verapamil hydrochloride 5 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
albumin human 10 g/250 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
protamine sulfate 50 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
albumin human 2 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
carbetocin 100 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Bordetella pertussis, acellular pertussis toxoid vaccine 10 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 5 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 30 units + tetanus toxoid vaccine 40 units injection, 0.5 mL vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
follitropin alfa 450 units (32.76 microgram)/0.75 mL injection, cartridge |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
follitropin alfa 300 units (21.84 microgram)/0.5 mL injection, cartridge |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
Bordetella pertussis, acellular pertussis toxoid vaccine 2.5 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 5 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units injection, 0.5 mL vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
follitropin alfa 900 units (65.52 microgram)/1.5 mL injection, cartridge |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
cefalotin 1 g injection, 1 g vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alanine 16 g/L + arginine 11.3 g/L + aspartic acid 3.4 g/L + glutamic acid 5.6 g/L + glycylglutamine monohydrate 30.27 g/L (equivalent to 10.27 g of glycine and 20 g of glutamine ) + glycyltyrosine dihydrate 3.45 g/L (equivalent to 940 mg of glycine and 2.28 g of tyrosine ) + histidine 6.8 g/L + isoleucine 5.6 g/L + leucine 7.9 g/L + lysine 9 g/L + methionine 5.6 g/L + phenylalanine 5.85 g/L + proline 6.8 g/L + serine 4.5 g/L + threonine 5.6 g/L + tryptophan 1.9 g/L + valine 7.3 g/L injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Midazolam (DBL) 15 mg/3 mL injection, 3 mL ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Atracurium Besylate (DBL) 25 mg/2.5 mL injection, 2.5 mL ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Reandron oily solution 1 g/4 mL injection, 4 mL ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
phenobarbital sodium 200 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
natalizumab 300 mg/15 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alanine 8 g/500 mL + arginine 5.65 g/500 mL + aspartic acid 1.7 g/500 mL + glutamic acid 2.8 g/500 mL + glycylglutamine monohydrate 15.14 g/500 mL (equivalent to 5.14 g of glycine and 10 g of glutamine ) + glycyltyrosine dihydrate 1.73 g/500 mL (equivalent to 470 mg of glycine and 1.14 g of tyrosine ) + histidine 3.4 g/500 mL + isoleucine 2.8 g/500 mL + leucine 3.95 g/500 mL + lysine 4.5 g/500 mL + methionine 2.8 g/500 mL + phenylalanine 2.93 g/500 mL + proline 3.4 g/500 mL + serine 2.25 g/500 mL + threonine 2.8 g/500 mL + tryptophan 950 mg/500 mL + valine 3.65 g/500 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
phenobarbital 200 mg (equivalent to phenobarbital sodium 219 mg)/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
phenobarbital sodium 20 mg/0.5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alanine 4 g/250 mL + arginine 2.83 g/250 mL + aspartic acid 850 mg/250 mL + glutamic acid 1.4 g/250 mL + glycylglutamine monohydrate 7.57 g/250 mL (equivalent to 2.57 g of glycine and 5 g of glutamine ) + glycyltyrosine dihydrate 860 mg/250 mL (equivalent to 235 mg of glycine and 570 mg of tyrosine ) + histidine 1.7 g/250 mL + isoleucine 1.4 g/250 mL + leucine 1.98 g/250 mL + lysine 2.25 g/250 mL + methionine 1.4 g/250 mL + phenylalanine 1.46 g/250 mL + proline 1.7 g/250 mL + serine 1.13 g/250 mL + threonine 1.4 g/250 mL + tryptophan 475 mg/250 mL + valine 1.83 g/250 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
mepivacaine hydrochloride 3% (54 mg/1.8 mL) injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lenograstim 13.4 million units (105 microgram) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
mepivacaine hydrochloride 3% (66 mg/2.2 mL) injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alanine 8.3 g/500 mL + arginine 4.6 g/500 mL + glycine 4.12 g/500 mL + histidine 1.92 g/500 mL + isoleucine 2.4 g/500 mL + leucine 2.92 g/500 mL + lysine hydrochloride 2.9 g/500 mL + methionine 1.6 g/500 mL + phenylalanine 2.24 g/500 mL + proline 2.72 g/500 mL + serine 2 g/500 mL + threonine 1.68 g/500 mL + tryptophan 720 mg/500 mL + tyrosine 160 mg/500 mL + valine 2.32 g/500 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG)) Connaught strain 1920 million CFU injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
lenograstim 263 microgram injection, 263 microgram vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
agalsidase beta 5 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alanine 10.35 g/500 mL + arginine 5.75 g/500 mL + glycine 5.15 g/500 mL + histidine 2.4 g/500 mL + isoleucine 3 g/500 mL + leucine 3.65 g/500 mL + lysine hydrochloride 2.9 g/500 mL + methionine 2 g/500 mL + phenylalanine 2.8 g/500 mL + proline 3.4 g/500 mL + serine 2.5 g/500 mL + threonine 2.1 g/500 mL + tryptophan 900 mg/500 mL + tyrosine 200 mg/500 mL + valine 2.9 g/500 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
agalsidase beta 35 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
alanine 5.7 g/500 mL + arginine 3.16 g/500 mL + glycine 2.83 g/500 mL + histidine 1.32 g/500 mL + isoleucine 1.65 g/500 mL + leucine 2.01 g/500 mL + lysine hydrochloride 1.6 g/500 mL + methionine 1.1 g/500 mL + phenylalanine 1.54 g/500 mL + proline 1.87 g/500 mL + serine 1.375 g/500 mL + threonine 1.155 g/500 mL + tryptophan 495 mg/500 mL + tyrosine 110 mg/500 mL + valine 1.595 g/500 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
tick antivenom 200 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sumatriptan 6 mg/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
diphtheria toxoid vaccine 30 units + tetanus toxoid vaccine 40 units + Bordetella pertussis, acellular pertussis toxoid vaccine 25 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 25 microgram + Bordetella pertussis, acellular pertactin vaccine 8 microgram + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
dactinomycin 500 microgram injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + Bordetella pertussis, acellular pertussis toxoid vaccine 8 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 8 microgram + Bordetella pertussis, acellular pertactin vaccine 2.5 microgram + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
taipan snake antivenom 12 000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
isoprenaline hydrochloride 1 in 5000 (200 microgram/mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
isoprenaline hydrochloride 1 in 5000 (1 mg/5 mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
triamcinolone acetonide 10 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
triamcinolone acetonide 40 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
dicobalt edetate 300 mg/20 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
amidotrizoate meglumine 2.6 g/10 mL + sodium amidotrizoate 400 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
amidotrizoate meglumine 65 g/250 mL + sodium amidotrizoate 10 g/250 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Atracurium Besylate (DBL) 50 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadopentetate dimeglumine 14.07 g/30 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadopentetate dimeglumine 7.035 g/15 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadopentetate dimeglumine 4.69 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
amidotrizoate meglumine 33 g/50 mL + sodium amidotrizoate 5 g/50 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Japanese encephalitis inactivated vaccine 6 microgram/0.5 mL injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
gadopentetate dimeglumine 46.9 g/100 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadopentetate dimeglumine 4.69 g/10 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadopentetate dimeglumine 9.38 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
antithymocyte immunoglobulin equine 250 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Mycobacterium bovis BCG Tice strain 500 million CFU injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
prilocaine hydrochloride 3% (66 mg/2.2 mL) + adrenaline (epinephrine) 1 in 300 000 (7.26 microgram/2.2 mL) injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
azathioprine 50 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cisplatin 100 mg/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
doxorubicin hydrochloride 50 mg/25 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
doxorubicin hydrochloride 10 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ondansetron 4 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cisplatin 50 mg/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
doxorubicin hydrochloride 200 mg/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
paricalcitol 10 microgram/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ondansetron 8 mg/4 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
paricalcitol 5 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cisplatin 10 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
doxorubicin hydrochloride 20 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
doxorubicin hydrochloride 100 mg/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza trivalent child vaccine 2008 injection, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza trivalent adult vaccine 2008 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
abciximab 10 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
red back spider antivenom 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
linezolid 600 mg/300 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
aminophylline 250 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
raltitrexed 2 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
phytomenadione 10 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
phytomenadione 2 mg/0.2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
thiopental sodium 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
interferon alfa-2a 4.5 million units (16.667 microgram)/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Fludarabine Phosphate (Ebewe) 50 mg/2 mL injection, 2 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
interferon alfa-2a 9 million units (33.333 microgram)/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefoxitin 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
interferon alfa-2a 3 million units (11.111 microgram)/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cefoxitin 2 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
interferon alfa-2a 6 million units (22.222 microgram)/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
calcium gluconate monohydrate 10% (5 g/50 mL) injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
papaverine hydrochloride 30 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
calcitonin salmon 100 units/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sodium selenate decahydrate 467 microgram/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
antithymocyte immunoglobulin rabbit 25 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
calcitonin salmon 50 units/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
papaverine hydrochloride 120 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sodium selenate decahydrate 111 microgram/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
calcium gluconate monohydrate 10% (1 g/10 mL) injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
zoledronic acid 4 mg/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|